Aims: To determine whether the Eiken particle agglutination test could be modified to make it sufficiently sensitive to screen blood samples collected on Guthrie cards for the presence of antibodies to Toxoplasma gondii; to evaluate the specificity of the modified system; and to compare seroepidemiological data on the prevalence of Tgondii in pregnant women. Methods: Simulated dried blood spots were prepared from sera from pregnant women booking for antenatal care. Eluates from the simulated dried blood spot cards and sera were tested in parallel using the modified test (1 in 5 dilution of latex) and the standard assay (neat latex particles) and endpoints determined. 
A further 103 eluates from simulated antibody negative blood spots gave a negative result (<4(<2 log2)) using the modified test. Figure 3 compares the distribution of antibody titres in sera using the standard technique and in eluates from Guthrie cards using the modified assay. The results show a similar The overall seroprevalence of antibodies to T gondii when screening neonates using the modified technique on eluates from Guthrie cards was 20-5% (214 out of 1043). A similar value would be expected with the mothers, as neonatal blood contains maternal antibody.
Discussion
The Eiken Toxoreagent test has been evaluated and found to be both sensitive and specific.82'-23 It is widely used in the United Kingdom for screening sera, but has not been evaluated for screening samples collected on Guthrie cards.
The modified test detected 98'8% of all positive sera, giving 1000% specificity when compared with the standard test. This is a sensitive and simple method for screening large numbers of samples. The prevalence of maternal antibody found in the present study of 1043 eluates from Guthrie cards was 20-5%. This is similar to the figure of 21 8% obtained when sera were screened from 1000 pregnant women attending an antenatal clinic in London using the standard test. 8 Using the standard Eiken test, sera with a titre of 1/16 are regarded as weakly positive and testing a follow up sample is recommended. If a screening procedure was introduced, all negative samples would need to be followed up two to three times during pregnancy. Although the modified latex test failed to detect two simulated samples in which the sera had a titre of 1/16, the outcome would be identical, as both these patients would have been retested. The standard technique was not sufficiently sensitive to detect low titres of antibody in eluates from Guthrie cards, but this problem was overcome by modifying the assay as described.
The advantages of the Eiken latex agglutination test are that it detects total antibody, is simple to perform, and requires no expensive capital equipment. The modified test retains these advantages and the cost is reduced from about 10 pence to 2 pence per well, between 50 and 100 times cheaper than many commercially available enzyme immunoassays.
The use of blood samples collected on Guthrie cards from both adults and babies also reduces the problems of transport and storage. This makes the test ideal for epidemiological surveillance in the United Kingdom or third world countries.
The method described can be used to screen rapidly large numbers of samples and the procedures can easily be semiautomated. The modified assay is ideally suited to link in with other neonatal screening programmes which rely on the use of blood collected on Guthrie cards. 
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